Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2022

Dec 19, 2022

29871_dirs_2022-12-19_19d01956-ec11-45b8-86d1-af3a51d4ec27.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-12-15

Reporting Person: Tully Sean (Sr MD Global Hd Rates & OTC)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-12-15 Common Stock Class A A 122 $155.22 Acquired 22087 Direct

Footnotes

F1: Reflects shares of CME Group Class A common stock purchased by Mr. Tully in our Employee Stock Purchase Plan ("ESPP") pursuant to his election made on May 19, 2022 for the ESPP purchase period of June 16, 2022 through December 15, 2022. In accordance with the terms of the ESPP, these shares were purchased based on 90% of the closing price of CME Group's Class A common stock on December 15, 2022.